Clinical trial / 2006
A heme-supplemented diet doubled urinary DHN-MA excretion in a randomized crossover human study.
Researchers evaluated urinary 8-iso-PGF(2)alpha and DHN-MA across two rat studies and a randomized crossover human trial testing four diets (60 g/d red meat baseline, 120 g/d red meat, baseline with heme iron, and baseline with non-heme iron). In humans, the heme-supplemented diet led to a 2-fold increase in urinary DHN-MA (P < 0.001), while 8-iso-PGF(2)alpha did not increase. In rats, high-heme diets dramatically increased DHN-MA in parallel with preneoplastic lesions (P < 0.0001) and moderately increased 8-iso-PGF(2)alpha (P < 0.0001).
- Study type
- Randomized crossover trial (plus rat studies)
- Who was studied
- Human participants (sample size not stated) and rats
- What was measured
- Urinary excretion of DHN-MA and 8-iso-PGF(2)alpha
THE PAPER
New marker of colon cancer risk associated with heme intake: 1,4-dihydroxynonane mercapturic acid.
Pierre F, Peiro G, Taché S, Cross AJ, Bingham SA, Gasc N, Gottardi G, Corpet DE, Guéraud F. Cancer Epidemiol Biomarkers Prev, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.